Search Results | MSF Science Portal

Journal Article

|

Research

Chippaux JP, Madec Y, Amta P, Ntone R, Noël G, et al.

2024-12-06 • Tropical Medicine and Infectious Disease

Snakes responsible for bites are rarely identified, resulting in a loss of information about snakebites from venomous species whose venom effects are poorly understood. A prospective ...

Journal Article

|

Research

Benhammou D, Chippaux JP, Ntone R, Madec Y, Amta P, et al.

2024-03-22 • Toxins

Snakebite envenomation (SBE) is a public health issue in sub-Saharan countries. Antivenom is the only etiological treatment. Excellent tolerance is essential in managing SBE successfully...

Journal Article

|

Research

Chippaux JP, Ntone R, Benhammou D, Madec Y, Noël G, et al.

2023-11-08 • PLOS Neglected Tropical Diseases

BACKGROUND
Snakebites is a serious public health issue but remains a neglected tropical disease. Data on antivenom effectiveness are urgently needed in Africa. We assessed effectiven...

Journal Article

|

Research

Pean P, Madec Y, Nerrienet E, Borand L, Laureillard D, et al.

2023-10-13 • Pathogens

IRIS is a common complication in HIV-infected patients treated for tuberculosis (TB) and cART. Our aim was to evaluate NK cell reconstitution in HIV-infected patients with TB-IRIS compar...

Journal Article

|

Research

Laureillard D, Marcy O, Madec Y, Chea S, Chan S, et al.

2013-10-23 • AIDS

To analyze cases of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the CAMbodian Early versus Late Introduction of Antiretrovirals (CAMELIA)...

Journal Article

|

Research

Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, et al.

2011-10-20 • New England Journal of Medicine

Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation...

Journal Article

|

Research

Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, et al.

2014-08-01 • Clinical Infectious Diseases

Shortening the interval between antituberculosis treatment onset and initiation of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human immunodeficiency vir...

Journal Article

|

Research

Madec Y, Szumilin E, Genevier C, Ferradini LLF, Balkan S, et al.

2009-04-27 • AIDS

BACKGROUND
In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretrovira...

Journal Article

|

Research

Taieb F, Dub T, Madec Y, Tondeur L, Chippaux JP, et al.

2018-10-25 • PLOS Neglected Tropical Diseases

Snakebite has only recently been recognized as a neglected tropical disease by the WHO. Knowledge regarding snakebites and its care is poor both at the population level, and at the healt...

Journal Article

|

Research

Borand L, Madec Y, Laureillard D, Chou M, Marcy O, et al.

2014-03-07 • PLOS One

OBJECTIVE
To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.

Journal Article

|

Research

Pean P, Nouhin J, Ratana M, Madec Y, Borand L, et al.

2019-08-27 • Frontiers in Immunology

Background: Human Immunodeficiency Virus 1 (HIV-1) and Mycobacterium Tuberculosis (Mtb) co-infected patients are commonly at risk of immune reconstitution inflammatory syndrome (IRIS) wh...

Journal Article

|

Research

Madec Y, Laureillard D, Pinoges LLP, Fernandez MAL, Prak N, et al.

2007-01-30 • AIDS

BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients. METHODS: Factors associated...

Science Portal

Snakebites in Cameroon by species whose effects are poorly described

Snakebites in Cameroon: Tolerance of a snake antivenom (Inoserp™ PAN-AFRICA) in Africa in real-life conditions

Real life condition evaluation of Inoserp PAN-AFRICA antivenom effectiveness in Cameroon

Natural killer repertoire restoration in TB/HIV co-infected individuals experienced an immune reconstitution syndrome (CAMELIA Trial, ANRS 12153)

Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries

Knowledge, attitude and practices of snakebite management amongest health workers in Cameroon: Need for continuous training and capacity building

Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)

High Activation of γδ T Cells and the γδ2 T-Cell Subset Is Associated With the Onset of Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome, ANRS 12153 CAPRI NK.

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia